Appoints Dr. Kurt Rasmussen, Former Eli Lilly Neuroscience Leader, NIH-NIDA Head of Therapeutics Division, as Chief Scientific Officer Names Co-Founder Dr. David E. Olson as Chief Innovation Officer, Head of Scientific Advisory Board BOSTON, July 6, 2021 /PRNewswire/ — Preclinical neuroscience company Delix Therapeutics (the “Company”), today announced the growth of its executive leadership team…


Previous articleMYND Life Sciences Provides Corporate Update
Next articleQ & A with Keeno Ahmed-Jones: Dismantling the Echo Chamber of the Psychedelic Renaissance